Sage Journals: Discover world-class research

Retricted access

Research article

First published 2005-08

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis

Robert M Herndon, Richard A Rudick, Frederick E Munschauer [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry

Melissa A Wright, Bradley J Barney, Skyler Peterson [...]

Journal of Child Neurology

Retricted access

Research article

First published 1998-11

Comparative Study of the Pharmacodynamic and Pharmacologic Effects of Betaseron ® and AVONEX ™

Gary J. Williams, Patricia L. Witt

Journal of Interferon & Cytokine Research

Retricted access

Other

First published 2007-5

Development of neutralizing antibodies to intramuscular interferon beta-1a (Avonex ®)

Suzan E. Goelz, L. Walt

Multiple Sclerosis Journal

Retricted access

Research article

First published 2005-10

Economic evaluation of Avonex® (interferon beta-1a) in patients following a single demyelinating event

Michael Iskedjian, John H Walker, Trevor Gray [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2002-10

Quality of life in multiple sclerosis: influence of interferon-β1a (Avonex®) treatment

P Vermersch, J de Seze, B Delisse [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2008-04

Avonex Combination Trial in relapsing—remitting MS: rationale,design and baseline data

JA Cohen, PA Calabresi, S. Chakraborty [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2001-06

Double-blind randomized multicenter dose-comparison study of interferon-β-1a (AVONEX): rationale,design and baseline data

European Study Group on Interferon-Beta-1a in MS

Multiple Sclerosis Journal

Retricted access

Research article

First published 2004-10

An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis

T L Vollmer, J T Phillips, A D Goodman [...]

Multiple Sclerosis Journal

Free access

Other

First published 2010-01

A randomized,blinded,parallel-group,pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis

Elliot M. Frohman, Gary Cutter, Gina Remington [...]

Therapeutic Advances in Neurological Disorders

Search results